Market Research Future published a Half
Cooked Research Report on “Global Blood Transfusion Diagnostics Market Research
Report-Forecast to 2027” – Market Analysis, Scope, Stake, Progress, Trends and
Forecast to 2027.
Ortho Clinical Diagnostics (U.S),
Immucor (U.S), Beckman Coulter (U.S), Grifols (Spain), Thermo Fisher
Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), bioMérieux
(France), Bio-Rad Laboratories, Inc. (U.S.), Siemens (Germany), Becton, Dickinson
and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.),
Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany),
DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S),
Hologic/Gen-Probe (U.S), Biokit (Spain).are some of the prominent players at
the forefront of competition in the global Blood Transfusion Diagnostics market
and top seven players are profiled in MRFR Analysis.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1126
Global
Blood Transfusion Diagnostics Market - Overview
Blood transfusion is an essential part
of providing healthcare services to the patients. Blood and blood products like
RBC’s, WBC’s, platelets and others are transfused from one person to another.
This requires screening tests which are vital before conducting blood
transfusion. Strict regulation governing the use and transfer of blood,
increasing awareness regarding blood transfusion and automation of blood banks
drive the growth of this market. Furthermore, increasing demand for diagnostic
and treatment devices in developed and developing countries further influence
the growth of the market. However, the growth of the market is restrained by
various factors such as risk involved in transmission of infectious disease
from one person to another without carrying out screening procedure.
Global Blood Transfusion Diagnostics
Market - Competitive Analysis
There is a significant increase in the
number of the company offering blood transfusion diagnostics. Some major
companies are trying to focus on new and advanced tests & products to gain
the market. Whereas, some are has used the technique of acquisition and collaboration
to gain the blood transfusion diseases market.
Hoffmann-La Roche AG:
- August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to
strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE
shareholders USD 190 million upfront and up to USD 235 million in
contingent product related milestones
- February 2015 : F. Hoffmann-La Roche AG announced the collaboration
with BioMed X for the development of Nanomaterial-Based Biosensors for
Near-Patient Testing
- September 2014: F. Hoffmann-La Roche AG launched Elecsys
anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian
reserve for pregnancy
Abbott:
- June, 2017: Alere shareholders approve amended merger with Abbott.
This merger will further strengthen the global presence of the company.
- August, 2016: Abbott announced the introduction of its new
“Alinity”, a family of next generation systems across immunoassay,
clinical chemistry, point of care, haematology, blood and plasma screening
and molecular diagnostics.
- April, 2016: The company received FDA approval for its companion
diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to
detect the 17p deletion in chronic lymphocytic leukemia patients, the
target population of a new drug from AbbVie.
- April, 2016: Abbott received FDA approval for its companion
diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to
detect the 17p deletion in chronic lymphocytic leukemia patients, the
target population of a new drug from AbbVie.
Bio-Rad Laboratories, Inc.:
July 2017: Bio-Rad Laboratories, Inc.,
a global provider of life science research and clinical diagnostic products
launched Amplichek I quality control for the testing of infectious diseases.
Global Blood Transfusion Diagnostics
Market - Regional Analysis
Globally, Americas account for the
largest market share in blood transfusion diagnostics market consists of two
regions namely North America and South America. Increasing in number of blood
banks, adoption of automation in blood banks, awareness programs in school
& medical institutes and demand of safe and reliable technology for blood
transfusion drive this market in North America. Increasing adoption of Nucleic
Acid Amplification for diagnosis of blood and blood products also contribute to
the growth of this market in North America. United States is the biggest market
place worldwide contributing 46% of total blood transfusion diagnostics market.
Ortho-Clinical Diagnostic is the largest transfusion diagnostic equipment and
solution provider with estimated market share of 7 to 8%. Medical institutes
conduct lecture and conference on safe blood transfusion for medical students
and also for patients. Europe blood transfusion diagnostics market has observed
stable growth owing to increasing demand for advanced diagnostic products.
Asia-Pacific is fastest growing market region for this market due to presence
of huge patient pool, and huge opportunity for the market growth. The Middle
East and Africa holds the least share in the market due to lack of awareness
among the people and limited development of medical sector.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126
No comments:
Post a Comment